Artisan Partners Limited Partnership purchased a new stake in HealthEquity, Inc. (NASDAQ:HQY – Free Report) during the fourth quarter, HoldingsChannel.com reports. The fund purchased 256,051 shares of the company’s stock, valued at approximately $24,568,000.
Several other institutional investors and hedge funds also recently made changes to their positions in the stock. Raymond James Trust N.A. boosted its position in shares of HealthEquity by 4.8% during the third quarter. Raymond James Trust N.A. now owns 2,905 shares of the company’s stock worth $238,000 after buying an additional 132 shares during the period. Citigroup Inc. boosted its position in HealthEquity by 73.0% during the 3rd quarter. Citigroup Inc. now owns 102,107 shares of the company’s stock worth $8,357,000 after acquiring an additional 43,084 shares during the last quarter. Cerity Partners LLC grew its stake in shares of HealthEquity by 15.1% during the 3rd quarter. Cerity Partners LLC now owns 17,259 shares of the company’s stock worth $1,413,000 after acquiring an additional 2,258 shares in the last quarter. BNP Paribas Financial Markets raised its holdings in shares of HealthEquity by 165.7% in the third quarter. BNP Paribas Financial Markets now owns 20,437 shares of the company’s stock valued at $1,673,000 after purchasing an additional 12,745 shares during the last quarter. Finally, Townsquare Capital LLC lifted its position in shares of HealthEquity by 3.9% in the third quarter. Townsquare Capital LLC now owns 22,292 shares of the company’s stock worth $1,825,000 after purchasing an additional 839 shares in the last quarter. Institutional investors and hedge funds own 99.55% of the company’s stock.
Insider Activity at HealthEquity
In related news, Director Robert W. Selander sold 5,750 shares of the business’s stock in a transaction on Monday, February 10th. The stock was sold at an average price of $111.29, for a total value of $639,917.50. Following the completion of the sale, the director now directly owns 78,219 shares in the company, valued at $8,704,992.51. The trade was a 6.85 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 2.20% of the stock is owned by company insiders.
HealthEquity Price Performance
Analyst Upgrades and Downgrades
HQY has been the topic of several recent research reports. Royal Bank of Canada lifted their price target on shares of HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research note on Tuesday, December 10th. Mizuho started coverage on HealthEquity in a report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 target price on the stock. Raymond James raised HealthEquity from an “outperform” rating to a “strong-buy” rating and lowered their price target for the stock from $120.00 to $115.00 in a research report on Tuesday. Wells Fargo & Company increased their price objective on HealthEquity from $110.00 to $125.00 and gave the company an “overweight” rating in a report on Wednesday, February 26th. Finally, KeyCorp dropped their price target on shares of HealthEquity from $120.00 to $110.00 and set an “overweight” rating on the stock in a research report on Monday, March 24th. One investment analyst has rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Buy” and a consensus target price of $112.23.
Check Out Our Latest Analysis on HQY
About HealthEquity
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Featured Articles
- Five stocks we like better than HealthEquity
- What Investors Need to Know to Beat the Market
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- JPMorgan: The ‘NVIDIA of Banking’ Poised for More Gains?
- How to Short Nasdaq: An Easy-to-Follow Guide
- Buy the Chewy Stock Reversal? Here’s Why Now Is the Time
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY – Free Report).
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.